Synuclein gamma as a biomarker of obesity and obesity-related disorders

摘要

Disclosed is a method of identifying γ-synuclein expression, as a biomarker for adiposity and adiposity related disorders. Identification of γ-synuclein expression includes agonists and antagonists thereof which may be used in pharmaceutical compositions for the treatment of adiposity related disorders.